AbbVie Inc. Operating Income
AbbVie Inc. (ABBV) reported Operating Income of $6.43 billion for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-03.
Financial Statements › Income Statement
us-gaap:OperatingIncomeLoss · last filed 2026-08-03
- AbbVie Inc. operating income (loss) for the quarter ending 2026-06-30 was $6.43B, a 31.43% increase year-over-year.
- AbbVie Inc. operating income (loss) for the quarter ending 2026-03-31 was $3.99B, a 6.88% increase year-over-year.
- AbbVie Inc. operating income (loss) for the quarter ending 2025-12-31 was $4.54B.
- AbbVie Inc. operating income (loss) for the quarter ending 2025-09-30 was $1.90B, a 50.30% decline year-over-year.
- AbbVie Inc. operating income (loss) for fiscal 2025 was $15.07B, a 64.99% increase from fiscal 2024.
- AbbVie Inc. operating income (loss) for fiscal 2024 was $9.14B, a 28.38% decline from fiscal 2023.
- AbbVie Inc. operating income (loss) for fiscal 2023 was $12.76B, a 29.59% decline from fiscal 2022.
- AbbVie Inc. operating income (loss) for fiscal 2022 was $18.12B, a 1.08% increase from fiscal 2021.
| Period end | Operating Income (Loss) 3 month | Operating Income (Loss) 3 month as first filed | Operating Income (Loss) 6 month | Operating Income (Loss) 6 month as first filed | Operating Income (Loss) 9 month | Operating Income (Loss) 9 month as first filed | Operating Income (Loss) 12 month | Operating Income (Loss) 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $6.43B 10-Q · filed 2026-08-03 | $10.42B 10-Q · filed 2026-08-03 | $14.97B derived: sum of 3 quarters · filed 2026-08-03 | $16.87B derived: sum of 4 quarters · filed 2026-08-03 | ||||
| 2026-03-31 | $3.99B 10-Q · filed 2026-05-08 | $8.53B derived: sum of 2 quarters · filed 2026-05-08 | $10.44B derived: sum of 3 quarters · filed 2026-05-08 | $15.33B derived: sum of 4 quarters · filed 2026-08-03 | ||||
| 2025-12-31 | $4.54B derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-20 | $6.45B derived: sum of 2 quarters · filed 2026-02-20 | $11.34B derived: sum of 3 quarters · filed 2026-08-03 | $15.07B 10-K · filed 2026-02-20 | ||||
| 2025-09-30 | $1.90B 10-Q · filed 2025-11-04 | $6.80B derived: sum of 2 quarters · filed 2026-08-03 | $10.53B 10-Q · filed 2025-11-04 | $9.04B derived: sum of 4 quarters · filed 2026-08-03 | ||||
| 2025-06-30 | $4.89B 10-Q · filed 2026-08-03 | $8.63B 10-Q · filed 2026-08-03 | $7.14B derived: sum of 3 quarters · filed 2026-08-03 | $10.97B derived: sum of 4 quarters · filed 2026-08-03 | ||||
| 2025-03-31 | $3.73B 10-Q · filed 2026-05-08 | $2.24B derived: sum of 2 quarters · filed 2026-05-08 | $6.07B derived: sum of 3 quarters · filed 2026-05-08 | $10.07B derived: sum of 4 quarters · filed 2026-05-08 | ||||
| 2024-12-31 | -$1.49B derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-20 | $2.34B derived: sum of 2 quarters · filed 2026-02-20 | $6.34B derived: sum of 3 quarters · filed 2026-02-20 | $9.14B 10-K · filed 2026-02-20 | ||||
| 2024-09-30 | $3.83B 10-Q · filed 2025-11-04 | $7.83B derived: sum of 2 quarters · filed 2025-11-04 | $10.63B 10-Q · filed 2025-11-04 | $13.82B derived: sum of 4 quarters · filed 2026-02-20 | ||||
| 2024-06-30 | $4.00B 10-Q · filed 2025-08-04 | $6.80B 10-Q · filed 2025-08-04 | $9.99B derived: sum of 3 quarters · filed 2026-02-20 | $12.27B derived: sum of 4 quarters · filed 2026-02-20 | ||||
| 2024-03-31 | $2.80B 10-Q · filed 2025-05-09 | $5.99B derived: sum of 2 quarters · filed 2026-02-20 | $8.27B derived: sum of 3 quarters · filed 2026-02-20 | $12.79B derived: sum of 4 quarters · filed 2026-02-20 | ||||
| 2023-12-31 | $3.19B derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-20 | $5.48B derived: sum of 2 quarters · filed 2026-02-20 | $9.99B derived: sum of 3 quarters · filed 2026-02-20 | $12.76B 10-K · filed 2026-02-20 | ||||
| 2023-09-30 | $2.28B 10-Q · filed 2024-11-04 | $6.79B derived: sum of 2 quarters · filed 2024-11-04 | $9.56B 10-Q · filed 2024-11-04 | $15.06B derived: sum of 4 quarters · filed 2025-02-14 | ||||
| 2023-06-30 | $4.51B 10-Q · filed 2024-08-07 | $7.28B 10-Q · filed 2024-08-07 | $12.78B derived: sum of 3 quarters · filed 2025-02-14 | $17.39B derived: sum of 4 quarters · filed 2025-02-14 | ||||
| 2023-03-31 | $2.77B 10-Q · filed 2024-05-03 | $8.27B derived: sum of 2 quarters · filed 2025-02-14 | $12.87B derived: sum of 3 quarters · filed 2025-02-14 | $16.17B derived: sum of 4 quarters · filed 2025-02-14 | ||||
| 2022-12-31 | $5.50B derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-14 | $10.11B derived: sum of 2 quarters · filed 2025-02-14 | $13.40B derived: sum of 3 quarters · filed 2025-02-14 | $18.12B 10-K · filed 2025-02-14 | ||||
| 2022-09-30 | $4.60B 10-Q · filed 2023-11-06 | $7.90B derived: sum of 2 quarters · filed 2023-11-06 | $12.62B 10-Q · filed 2023-11-06 | $17.69B derived: sum of 4 quarters · filed 2024-02-20 | ||||
| 2022-06-30 | $3.29B 10-Q · filed 2023-08-07 | $8.01B 10-Q · filed 2023-08-07 | $13.09B derived: sum of 3 quarters · filed 2024-02-20 | $17.39B derived: sum of 4 quarters · filed 2024-02-20 | ||||
| 2022-03-31 | $4.72B 10-Q · filed 2023-05-05 | $9.79B derived: sum of 2 quarters · filed 2024-02-20 | $14.10B derived: sum of 3 quarters · filed 2024-02-20 | $18.54B derived: sum of 4 quarters · filed 2024-02-20 | ||||
| 2021-12-31 | $5.07B derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-20 | $9.38B derived: sum of 2 quarters · filed 2024-02-20 | $13.82B derived: sum of 3 quarters · filed 2024-02-20 | $17.92B 10-K · filed 2024-02-20 | ||||
| 2021-09-30 | $4.31B 10-Q · filed 2022-11-04 | $8.75B derived: sum of 2 quarters · filed 2022-11-04 | $12.85B 10-Q · filed 2022-11-04 | $16.60B derived: sum of 4 quarters · filed 2023-02-17 | ||||
| 2021-06-30 | $4.44B 10-Q · filed 2022-08-04 | $8.54B 10-Q · filed 2022-08-04 | $12.30B derived: sum of 3 quarters · filed 2023-02-17 | $15.55B derived: sum of 4 quarters · filed 2023-02-17 | ||||
| 2021-03-31 | $4.10B 10-Q · filed 2022-05-06 | $7.86B derived: sum of 2 quarters · filed 2023-02-17 | $11.11B derived: sum of 3 quarters · filed 2023-02-17 | $11.86B derived: sum of 4 quarters · filed 2023-02-17 | ||||
| 2020-12-31 | $3.75B derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-17 | $7.01B derived: sum of 2 quarters · filed 2023-02-17 | $7.76B derived: sum of 3 quarters · filed 2023-02-17 | $11.36B 10-K · filed 2023-02-17 | ||||
| 2020-09-30 | $3.25B 10-Q · filed 2021-11-02 | $4.01B derived: sum of 2 quarters · filed 2021-11-02 | $7.61B 10-Q · filed 2021-11-02 | $11.57B derived: sum of 4 quarters · filed 2022-02-18 | ||||
| 2020-06-30 | $752.00M 10-Q · filed 2021-08-02 | $4.36B 10-Q · filed 2021-08-02 | $8.31B derived: sum of 3 quarters · filed 2022-02-18 | $10.93B derived: sum of 4 quarters · filed 2022-02-18 | ||||
| 2020-03-31 | $3.60B 10-Q · filed 2021-05-07 | $7.56B derived: sum of 2 quarters · filed 2022-02-18 | $10.18B derived: sum of 3 quarters · filed 2022-02-18 | $13.58B derived: sum of 4 quarters · filed 2022-02-18 | ||||
| 2019-12-31 | $3.96B derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-18 | $6.57B derived: sum of 2 quarters · filed 2022-02-18 | $9.97B derived: sum of 3 quarters · filed 2022-02-18 | $12.98B 10-K · filed 2022-02-18 | ||||
| 2019-09-30 | $2.62B 10-Q · filed 2020-11-04 | $6.02B derived: sum of 2 quarters · filed 2020-11-04 | $9.03B 10-Q · filed 2020-11-04 | $6.59B derived: sum of 4 quarters · filed 2021-02-19 | ||||
| 2019-06-30 | $3.40B 10-Q · filed 2020-08-04 | $6.41B 10-Q · filed 2020-08-04 | $3.97B derived: sum of 3 quarters · filed 2021-02-19 | $7.13B derived: sum of 4 quarters · filed 2021-02-19 | ||||
| 2019-03-31 | $3.01B 10-Q · filed 2020-05-08 | $569.00M derived: sum of 2 quarters · filed 2021-02-19 | $3.73B derived: sum of 3 quarters · filed 2021-02-19 | $6.49B derived: sum of 4 quarters · filed 2021-02-19 | ||||
| 2018-12-31 | -$2.44B derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-19 | $718.00M derived: sum of 2 quarters · filed 2021-02-19 | $3.48B derived: sum of 3 quarters · filed 2021-02-19 | $6.38B 10-K · filed 2021-02-19 | ||||
| 2018-09-30 | $3.16B 10-Q · filed 2019-11-06 | $5.92B derived: sum of 2 quarters · filed 2019-11-06 | $8.82B 10-Q · filed 2019-11-06 | $10.61B derived: sum of 4 quarters · filed 2020-02-21 | ||||
| 2018-06-30 | $2.76B 10-Q · filed 2019-08-05 | $5.67B 10-Q · filed 2019-08-05 | $7.45B derived: sum of 3 quarters · filed 2020-02-21 | $10.14B derived: sum of 4 quarters · filed 2020-02-21 | ||||
| 2018-03-31 | $2.90B 10-Q · filed 2019-05-03 | $4.68B derived: sum of 2 quarters · filed 2020-02-21 | $7.38B derived: sum of 3 quarters · filed 2020-02-21 | $10.04B derived: sum of 4 quarters · filed 2020-02-21 | ||||
| 2017-12-31 | $1.78B derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-21 | $4.48B derived: sum of 2 quarters · filed 2020-02-21 | $7.14B derived: sum of 3 quarters · filed 2020-02-21 | $9.54B 10-K · filed 2020-02-21 | $9.59B 10-K · filed 2018-02-16 | |||
| 2017-09-30 | $2.69B 10-Q · filed 2018-11-07 | $2.71B 10-Q · filed 2017-11-07 | $5.36B derived: sum of 2 quarters · filed 2018-11-07 | $7.76B 10-Q · filed 2018-11-07 | $7.80B 10-Q · filed 2017-11-07 | $10.08B derived: sum of 4 quarters · filed 2019-02-27 | ||
| 2017-06-30 | $2.66B 10-Q · filed 2018-08-07 | $2.67B 10-Q · filed 2017-08-07 | $5.07B 10-Q · filed 2018-08-07 | $5.09B 10-Q · filed 2017-08-07 | $7.38B derived: sum of 3 quarters · filed 2019-02-27 | $9.74B derived: sum of 4 quarters · filed 2019-02-27 | ||
| 2017-03-31 | $2.41B 10-Q · filed 2018-05-04 | $2.42B 10-Q · filed 2017-05-05 | $4.72B derived: sum of 2 quarters · filed 2019-02-27 | $7.08B derived: sum of 3 quarters · filed 2019-02-27 | $9.47B derived: sum of 4 quarters · filed 2019-02-27 | |||
| 2016-12-31 | $2.31B derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-27 | $4.67B derived: sum of 2 quarters · filed 2019-02-27 | $7.06B derived: sum of 3 quarters · filed 2019-02-27 | $9.34B 10-K · filed 2019-02-27 | $9.38B 10-K · filed 2017-02-17 | |||
| 2016-09-30 | $2.36B 10-Q · filed 2017-11-07 | $4.75B derived: sum of 2 quarters · filed 2017-11-07 | $7.03B 10-Q · filed 2017-11-07 | $9.14B derived: sum of 4 quarters · filed 2018-02-16 | ||||
| 2016-06-30 | $2.39B 10-Q · filed 2017-08-07 | $4.67B 10-Q · filed 2017-08-07 | $6.78B derived: sum of 3 quarters · filed 2018-02-16 | $8.66B derived: sum of 4 quarters · filed 2018-02-16 | ||||
| 2016-03-31 | $2.28B 10-Q · filed 2017-05-05 | $4.39B derived: sum of 2 quarters · filed 2018-02-16 | $6.28B derived: sum of 3 quarters · filed 2018-02-16 | $8.13B derived: sum of 4 quarters · filed 2018-02-16 | ||||
| 2015-12-31 | $2.11B derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-16 | $4.00B derived: sum of 2 quarters · filed 2018-02-16 | $5.85B derived: sum of 3 quarters · filed 2018-02-16 | $7.54B 10-K · filed 2018-02-16 | ||||
| 2015-09-30 | $1.89B 10-Q · filed 2016-11-07 | $3.74B derived: sum of 2 quarters · filed 2016-11-07 | $5.42B 10-Q · filed 2016-11-07 | $5.01B derived: sum of 4 quarters · filed 2017-02-17 | ||||
| 2015-06-30 | $1.85B 10-Q · filed 2016-08-05 | $3.54B 10-Q · filed 2016-08-05 | $3.12B derived: sum of 3 quarters · filed 2017-02-17 | $4.08B derived: sum of 4 quarters · filed 2017-02-17 | ||||
| 2015-03-31 | $1.69B 10-Q · filed 2016-05-06 | $1.27B derived: sum of 2 quarters · filed 2017-02-17 | $2.23B derived: sum of 3 quarters · filed 2017-02-17 | $3.75B derived: sum of 4 quarters · filed 2017-02-17 | ||||
| 2014-12-31 | -$415.00M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-17 | $545.00M derived: sum of 2 quarters · filed 2017-02-17 | $2.06B derived: sum of 3 quarters · filed 2017-02-17 | $3.41B 10-K · filed 2017-02-17 | ||||
| 2014-09-30 | $960.00M 10-Q · filed 2015-11-06 | $2.48B derived: sum of 2 quarters · filed 2015-11-06 | $3.83B 10-Q · filed 2015-11-06 | $5.36B derived: sum of 4 quarters · filed 2016-02-19 | ||||
| 2014-06-30 | $1.51B 10-Q · filed 2015-08-07 | $2.87B 10-Q · filed 2015-08-07 | $4.40B derived: sum of 3 quarters · filed 2016-02-19 | $5.77B derived: sum of 4 quarters · filed 2016-02-19 | ||||
| 2014-03-31 | $1.35B 10-Q · filed 2015-05-08 | $2.89B derived: sum of 2 quarters · filed 2016-02-19 | $4.26B derived: sum of 3 quarters · filed 2016-02-19 | $5.71B derived: sum of 4 quarters · filed 2016-02-19 | ||||
| 2013-12-31 | $1.53B derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-19 | $2.91B derived: sum of 2 quarters · filed 2016-02-19 | $4.36B derived: sum of 3 quarters · filed 2016-02-19 | $5.66B 10-K · filed 2016-02-19 | ||||
| 2013-09-30 | $1.37B 10-Q · filed 2014-11-07 | $2.82B derived: sum of 2 quarters · filed 2014-11-07 | $4.13B 10-Q · filed 2014-11-07 | $5.95B derived: sum of 4 quarters · filed 2015-02-20 | ||||
| 2013-06-30 | $1.45B 10-Q · filed 2014-08-07 | $2.76B 10-Q · filed 2014-08-07 | $4.58B derived: sum of 3 quarters · filed 2015-02-20 | $6.17B derived: sum of 4 quarters · filed 2015-02-20 | ||||
| 2013-03-31 | $1.30B 10-Q · filed 2014-05-09 | $3.13B derived: sum of 2 quarters · filed 2015-02-20 | $4.72B derived: sum of 3 quarters · filed 2015-02-20 | $6.14B derived: sum of 4 quarters · filed 2015-02-20 | ||||
| 2012-12-31 | $1.82B derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-20 | $3.42B derived: sum of 2 quarters · filed 2015-02-20 | $4.84B derived: sum of 3 quarters · filed 2015-02-20 | $5.82B 10-K · filed 2015-02-20 | ||||
| 2012-09-30 | $1.60B 10-Q · filed 2013-11-12 | $3.02B derived: sum of 2 quarters · filed 2013-11-12 | $4.00B 10-Q · filed 2013-11-12 | |||||
| 2012-06-30 | $1.42B 10-Q · filed 2013-08-09 | $2.40B 10-Q · filed 2013-08-09 | ||||||
| 2012-03-31 | $978.00M 10-Q · filed 2013-05-08 | |||||||
| 2011-12-31 | $3.62B 10-K · filed 2014-02-21 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Merck & Co., Inc. (MRK) | United States | $365.215B | 99.96 |
| JOHNSON & JOHNSON (JNJ) | United States | $652.528B | 29.10 |
| ABBOTT LABORATORIES (ABT) | United States | $176.045B | 28.47 |
| PFIZER INC (PFE) | United States | $162.042B | 31.94 |
| VERTEX PHARMACEUTICALS INC / MA (VRTX) | United States | $132.481B | 28.56 |
| BRISTOL MYERS SQUIBB CO (BMY) | United States | $125.637B | 12.67 |
| REGENERON PHARMACEUTICALS, INC. (REGN) | United States | $74.751B | 21.53 |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |